Ascletis says its lead amylin tablet ASC36o lasted about 7 days in monkeys and is now in a US Phase I study, with human PK data expected by the end of 2026.
Recap by typeshit. Full story at Yahoo Finance.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
In rats and minipigs, doses too small to cut weight still reduced heart scarring and stiffness tied to a common heart failure type, researchers report.
German researchers made synthetic versions of peptides from axolotl skin mucus, and some slowed the growth of MRSA, the drug-resistant bacteria.
10:45
The nutrition and exercise graduate walks through her food picks for people on retatrutide, aimed at holding onto muscle during weight loss.
The two actors chat about what keeps them working, how they approach fitness, and look back on Mona Singh's show Jassi Jaissi Koi Nahin.
18:05
Dr. Stirrett walks through three pointers for people on tirzepatide, framed as part of a broader GLP-1 guide. His advice, not a set protocol.
Loading…